Partnership to Develop Tissue Dissection Solution for Path Labs

Molecular pathology Innovator Xyall BV has joined a multi-year, strategic partnership with Motic, a world leader in microscopy and digital pathology systems to develop an automated, high-precision table-top tumour tissue dissection solution for hospital-based molecular pathology laboratories.

In addition to joint product development, Xyall and Motic have established a reseller and support agreement to accelerate the delivery of these offerings into Chinese and Asian markets. Xyall is expecting to have its first digital pathology table-top products ready for launch in autumn next year. In 2019, Xyall partnered with high-tech engineering company Sioux to bring high technology (medical) robotic solutions and machine learning expertise to its platform.

Tissue dissection remains a labour-intensive process at risk of error and cross contamination. “Xyall aims to transform the way laboratories carry this out, by delivering an automatic solution with greater accuracy, throughput and quality control,” explained Guido du Pree, Xyall’s CEO."We are delighted to join forces with Motic, Their knowledge and experience in optics, imaging, pathology workflow, and strong market position in digital pathology, especially in Asia, is an enormous asset and will boost our development and commercialization. The combined expertise of our strategic partners creates a dynamic, conviction-led alliance - to create and drive forward our unique global solutions for both high volume and hospital-based molecular pathology laboratories.”

Richard Yeung, Motic’s CEO, added: “Motic is not only a trusted global provider of microscopy and digital whole slide imaging solutions, but also operates one of the largest tele-pathology consultation platforms in the world. By teaming up with Xyall and Sioux, we are confident that we have created the synergies needed to build another milestone in digital pathology industry.”